Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Security class unavailable · CUSIP: 68062P106
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 700,100
- Percent of class
- 1.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000011
- Form type
- SC 13G
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Feb 12, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership